FACTORS AFFECTING BIOAVAILABILITY OF PHENYTOIN

Publisher Website
Google Scholar
Abstract
The bioavailability of 7 phenytoin (DPH) formulations, 5 brands of tablets and 2 suspensions, was measured in a cross-over study with 6 healthy volunteers. Single doses of 600 mg of DPH were used and the bioavailability was determined as the area under the serum DPH concentration-time curve (AUC). Highly significant differences between the bioavailability of various products were found. The highest bioavailability was obtained with the suspension prepared from the micronized raw material of DPH and the lowest bioavailability (26% of that of the former suspension) with the tablets having the largest particle size of DPH. The in vitro dissolution rate of the products in borate buffer at pH 9 showed a significant (P < 0.01; r = 0.93) correlation with the in vivo bioavailability of the DPH products. In addition to the particle size, several other formulation factors were important for dissolution rate and absorption characteristics of DPH products. The properly performed measurements of the in vitro dissolution rate can be used s a preliminary screening test in predicting the bioavailability of DPH products.

This publication has 1 reference indexed in Scilit: